Geniposide Alleviates Glucocorticoid-Induced Inhibition of Osteogenic Differentiation in MC3T3-E1 Cells by ERK Pathway

Glucocorticoid (GC) therapy is the leading cause of secondary osteoporosis and the therapeutic and preventative drugs for GC-induced osteoporosis are limited. In this study, we investigated the protective effects of geniposide on dexamethasone (DEX)-induced osteogenic inhibition in MC3T3-E1 cells. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Baocheng, Wu, Jiahuan, Li, Yongmei, Wu, Xuejun, Zeng, Zhanwei, Zhou, Chenhui, Xu, Daohua, Wu, Longhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482204/
https://www.ncbi.nlm.nih.gov/pubmed/31057410
http://dx.doi.org/10.3389/fphar.2019.00411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482204/
https://www.ncbi.nlm.nih.gov/pubmed/31057410
http://dx.doi.org/10.3389/fphar.2019.00411

Ejemplares similares